Sps — Competitive Intelligence Brief

Sps (SODIUM POLYSTYRENE SULFONATE) competitive landscape: 5 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Potassium Binder [EPC]. Area: Gastroenterology.

marketed Potassium Binder [EPC] Gastroenterology Small molecule

Target snapshot

Sps (SODIUM POLYSTYRENE SULFONATE) — Concordia.

Comparator set (5 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Sps TARGET	SODIUM POLYSTYRENE SULFONATE	Concordia	marketed	Potassium Binder [EPC]		1958-01-01
sodium zirconium cyclic silicate	sodium zirconium cyclic silicate	Peking University First Hospital	marketed	Potassium binder	Potassium ion (K+) in gastrointestinal lumen
LOKELMA 5 GM Powder for Oral Suspension	LOKELMA 5 GM Powder for Oral Suspension	Steno Diabetes Center Copenhagen	marketed	Potassium binder	Potassium ion (K+) in gastrointestinal tract
Patiromer Oral Product	Patiromer Oral Product	Wake Forest University Health Sciences	marketed	Potassium binder	Potassium ion (K+) in gastrointestinal lumen
Zirconium Cyclosilicate	Zirconium Cyclosilicate	AstraZeneca	marketed	Potassium binder	Potassium ion (K+) in gastrointestinal tract
Lokelma Oral Product	Lokelma Oral Product	St George's, University of London	phase 3	Potassium binder	Potassium ion (K+) in gastrointestinal lumen

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Potassium Binder [EPC] class)

1. Concordia · 1 drug in this class